Inclusion Criteria:  Adult, aged 19 years or above New onset of symptoms suggestive of COVID-19 (fever, cough, soar throat, etc) or diagnosed with COVID-19 within 7 days of participant being seen at visit 1 In the Investigator's opinion, is able and willing to comply with all trial requirements  Exclusion Criteria:  A condition requiring invasive oxygen support; History of hypersensitivity to budesonide and arformoterol Pregnancy, Breast-feeding Participation in other clinical studies within 4 weeks prior to enrollment in this study. Refusal of the patient to continue participating in the study/withdrawal of informed consent by the patient.